The MS-LINK™ Outcomes Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2182 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-24

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS

NCT00813969

Relapsing-Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis Progressive Relapsing Multiple Sclerosis

COMPLETED PHASE1

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care

NCT07280871

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Chronic Progressive Clinically Isolated Syndrome +1 more

NOT_YET_RECRUITING

Next-Gen MS: Feed-forward PRO Data for MS Research

NCT04907305

Multiple Sclerosis (MS)

TERMINATED

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

NCT05663853

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive

COMPLETED

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease

NCT01804647

Multiple Sclerosis (MS) Relapsing-Remitting MS Primary Progressive MS +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multiple Sclerosis (MS)

Data from the participants with diagnosed MS treated and untreated will be part of this study. Medical records of participants will be used to collect demographics and data pertaining to Multiple Sclerosis (MS) management.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants willing and able to provide written informed consent
* Participants willing to be contacted while participating in the study for recruitment into sub-studies that may be relevant to them
* Participants willing and able to complete PROs on a monthly basis and document events of interest as they occur
* Participants willing to participate in additional follow up at the site for at least three years

Exclusion Criteria

* Unable to complete questionnaires in English
* Unable to consistently access the Internet
* Participants participating in interventional clinical drug trials at baseline

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No